Abstract:Introduction Inflatable penile prostheses (IPP) are the gold standard treatment for erectile dysfunction refractory to conservative therapies. However, infection remains a significant concern and the presence of microbial biofilms on both infected and non-infected devices has recently been demonstrated. Various antimicrobials are used for prophylaxis intraoperatively and postoperatively. It remains unknown how these antimicrobials affect the growth of bacteria and their associated biofilms. We sought to assess how commonly used antimicrobials influenced growth of bacterial isolates previously isolated from both non-infected and infected devices, obtained during revisional surgery. Objective The goal of this study was to evaluate growth of bacterial isolates previously obtained from non-infected and infected IPPs. Isolates were exposed to single or multi-antibiotic combinations to assess degree of inhibition of bacterial growth. Methods In this IRB-approved study, 35 bacterial isolates had been previously obtained from patients who had been consented for IPP revision or replacement secondary to mechanical failure, pain, or device infection. Bacteria were plated on brain-heart-infusion (BHI) agar plates and allowed to incubate for 48 hours. Standard-sized antibiotic discs were introduced into the grown bacterial colonies consisting of the following single or multi-agent regimens: bacitracin, cefaclor, cephazolin, gentamicin, levofloxacin, trimethoprim-sulfamethoxazole, tobramycin, vancomycin, piperacillin/tazobactam, gentamicin + piperacillin/tazobactam, gentamicin + cephazolin, and gentamicin + vancomycin. Zones of inhibition (ZOI) were measured after placement of the antibiotic discs in the bacterial colonies. Statistics were analyzed with false discovery rate corrected, one-sample t-tests. Quantification of antibiotic resistance was defined as follows: Resistant: ZOI not significantly different from 0 in one sample t-test Susceptible: ZOI significantly greater than 0, but mean is 20mm Taxonomic classification of bacterial isolates was provided by extracting DNA from pure cultures and sequencing the full length 16S rRNA gene using Sanger sequencing, after amplification with two different primer sets to provide overlapping sequence regions. Results Of the antibiotics tested, TMP-SMX was found to have the highest percentage of resistant isolates (54.3%) of the 35 tested, with bacitracin having the second most (40%). Both tobramycin and TMP-SMX had 0.0% of isolates be exceptionally susceptible. Combination piperacillin/tazobactam was found to have the highest percentage of exceptionally susceptible isolates (11.4%). A large majority of isolates were highly susceptible to gentamicin + piperacillin/tazobactam (91.4%), piperacillin/tazobactam (74.3%), gentamicin + cefazolin (74.3%), and levofloxacin (88.6%), while greater than half of isolates were highly susceptible to cefazolin (62.9%) and cefaclor (54.3%)." Conclusions Our results demonstrate that cefaclor or bacitracin prevented growth of bacterial isolates obtained from IPPs explanted for mechanical failure, pain or infection. Further investigation is needed to characterize how intraoperative and postoperative antibiotic influences a symbiotic or dysbiotic community of microbes on the surface of penile prostheses. By better understanding the interactions between microbes, antibiotics and host, novel therapeutics might promote a non-infected, symbiotic microenvironment. Disclosure Yes, this is sponsored by industry/sponsor: Coloplast corporation. Clarification: Industry funding only - investigator initiated and executed study. Any of the authors act as a consultant, employee or shareholder of an industry for: Coloplast, boston scientific.

Antibiotic pharmacokinetics in infected pleural effusions

Pathogens distribution and drug resistance of pleural effusion specimens in 247 patients with chronic liver disease

Pharmacokinetic/Pharmacodynamic Analysis Of Imipenem In Plasma And Peritoneal Liquid In Chinese Patients With Perforated Upper Gastrointestinal Tract

Empirical polymyxin B therapy in febrile neutropenic patients with hematological diseases: A prospective, multicenter, observational clinical study

Sustained release of bactericidal concentrations of penicillin in the pleural space via an antibiotic-eluting pigtail catheter coated with electrospun nanofibers: results from in vivo and in vitro studies

Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia

Diagnosis and management of pleural infection

A Systematic Review of the Pharmacokinetics and Pharmacodynamics of Novel Beta-Lactams and Beta-Lactam with Beta-Lactamase Inhibitor Combinations for the Treatment of Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

Empiric Antibiotic Therapy in 1402 Children With Parapneumonic Effusion/Pleural Empyema in Germany: A Long-term Surveillance Study

Understanding the nebulisation of antibiotics: the key role of lung microdialysis studies

Identification of Microbiome Etiology Associated With Drug Resistance in Pleural Empyema

Infection and the Evaluation of Biomarkers in Obstetrics and Gynecology Patients with Infectious Disease: a Retrospective Observational Study from Clinical Pharmacists' Consultation Experience.

In vitro killing of drug susceptible and multidrug resistant bacteria by amikacin considering pulmonary drug concentrations based on an inhaled formulation

Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model

Penetration of Antibiotics into Subcutaneous and Intramuscular Interstitial Fluid: A Meta-Analysis of Microdialysis Studies in Adults

The tuberculous pleural effusion

(128) Characterizing Antibiotic Susceptibility of the Penile Prosthesis Microbiome

Antibiotic De-escalation Patterns and Outcomes in Critically Ill Patients with Suspected Pneumonia as Informed by Bronchoalveolar Lavage Results

Clinically used broad-spectrum antibiotics compromise inflammatory monocyte-dependent antibacterial defense in the lung

The Kinetics of Cefuroxime in Ascitic and Pleural Fluid.

Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenation